Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,078 | 199 | 97.9% |
| Education | $64.54 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $571.66 | 31 | $0 (2024) |
| ABBVIE INC. | $488.99 | 39 | $0 (2024) |
| Amgen Inc. | $333.25 | 19 | $0 (2024) |
| PFIZER INC. | $230.66 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $226.58 | 16 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $165.14 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $157.31 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.77 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $75.58 | 5 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $75.11 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.52 | 50 | Novo Nordisk Inc ($297.38) |
| 2023 | $731.49 | 49 | Novo Nordisk Inc ($181.07) |
| 2022 | $771.90 | 53 | Amgen Inc. ($167.31) |
| 2021 | $519.68 | 34 | Amarin Pharma Inc. ($114.58) |
| 2020 | $205.81 | 15 | Amarin Pharma Inc. ($112.00) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Obesity | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Obesity | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINE | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.96 | General |
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardio-renal | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,204 | 3,496 | $534,391 | $264,301 |
| 2022 | 22 | 2,406 | 3,902 | $600,112 | $287,900 |
| 2021 | 25 | 2,764 | 3,883 | $556,102 | $276,087 |
| 2020 | 14 | 1,359 | 1,434 | $201,338 | $99,335 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 4 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 57 | 64 | $4,928 | $2,065 | 41.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 94 | 94 | $3,572 | $1,491 | 41.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 27 | 28 | $1,848 | $271.88 | 14.7% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 11 | 11 | $363.00 | $161.48 | 44.5% |
About Dr. Michael Sperling, M.D
Dr. Michael Sperling, M.D is a Internal Medicine healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1326579392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sperling, M.D has received a total of $3,142 in payments from pharmaceutical and medical device companies, with $913.52 received in 2024. These payments were reported across 201 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,078).
As a Medicare-enrolled provider, Sperling has provided services to 8,733 Medicare beneficiaries, totaling 12,715 services with total Medicare billing of $927,624. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Little River, SC
- Active Since 03/22/2017
- Last Updated 02/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326579392
Products in Payments
- Ozempic (Drug) $247.99
- Vascepa (Drug) $226.58
- Otezla (Drug) $207.00
- QULIPTA (Drug) $202.29
- ELIQUIS (Drug) $199.29
- Wegovy (Drug) $196.31
- VRAYLAR (Drug) $156.32
- XIFAXAN (Drug) $104.77
- UBRELVY (Drug) $94.96
- Rybelsus (Drug) $88.08
- FARXIGA (Drug) $82.24
- Kerendia (Drug) $75.58
- XARELTO (Drug) $73.89
- EVENITY (Biological) $67.52
- Dexcom G6 Transmitter (Medical Supply) $58.26
- GEMTESA (Drug) $54.90
- GVOKE PFS (Drug) $54.03
- ENTRESTO (Drug) $53.96
- AREXVY (Drug) $50.00
- SHINGRIX (Biological) $48.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little River
Dr. Yuxuan Mao, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $87,660
Marc Comianos, Do, DO
Internal Medicine — Payments: $17,613
Kevin Dineen, Md, MD
Internal Medicine — Payments: $14,769
Dr. Donny Huynh, M.d, M.D
Internal Medicine — Payments: $8,317
Dr. Ruth Wieland, Md, MD
Internal Medicine — Payments: $7,362
Dr. Robert Prinzi, Md, MD
Internal Medicine — Payments: $3,545